BUDDY: An interactive web platform to accelerate the functional modeling of human missense variants using Saccharomyces cerevisiae orthologs
The authors present BUDDY, an interactive web platform that streamlines the functional modeling of human missense variants in *Saccharomyces cerevisiae* by integrating bioinformatic tools, structural visualization, and AI-assisted experimental design, thereby accelerating variant analysis and making it accessible to users without prior bioinformatics training.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Modern medicine has entered an era where reading a person's genetic code is becoming routine. Scientists can now sequence the entire DNA of a patient quickly and affordably, revealing thousands of tiny differences between individuals. However, this speed has created a new bottleneck. While researchers can easily find these genetic differences, known as variants, they often cannot say what the differences actually do. Many of these changes are labeled as "variants of uncertain significance." They are genetic typos that might cause disease, or they might be harmless quirks. Without knowing which is which, doctors cannot offer precise diagnoses or tailored treatments, leaving patients in a state of uncertainty.
To solve this, scientists need to test these variants in the lab to see how they affect biological function. One powerful way to do this is by using yeast, a microscopic fungus that shares many of the same basic biological processes as humans. Because yeast grows quickly and is easy to manipulate, it serves as a fast and efficient testing ground. If a human genetic error causes a problem in a yeast cell, researchers can observe that failure and learn how the error works. The challenge has been that setting up these tests is a slow, complicated process that requires navigating many different computer databases and writing complex code to match human genes to their yeast counterparts. This barrier has kept many researchers and students from using this powerful tool.
A team of researchers has now built a new digital tool designed to remove these technical hurdles. Called BUDDY, which stands for Bioinformatic Utility for Diagnostic Discovery in Yeast, this is a web-based platform that acts as a central hub for the entire process. Instead of forcing a scientist to jump between multiple websites to find gene matches, align sequences, and design experiments, BUDDY brings all these steps together into a single, easy-to-use interface. The system connects directly to major genetic databases to pull in information about human variants and then automatically finds the corresponding genes in yeast. It then performs the necessary comparisons to ensure the human and yeast versions are similar enough to be useful for testing.
The platform goes beyond simple matching. It includes a visualizer that allows users to see the three-dimensional shapes of both the human and yeast proteins side by side, highlighting exactly where a genetic error sits within the structure. It also calculates how likely a specific variant is to be harmful based on existing data. Perhaps most significantly, the tool incorporates an artificial intelligence assistant. This feature does not just display data; it reads the gathered information and suggests specific experiments. It can recommend which biological tests to run in the yeast lab to see if a variant causes a problem, and it even designs the precise DNA instructions needed to edit the yeast genome to introduce the human error. The system is smart enough to filter its suggestions based on safety, ensuring that the proposed experiments are suitable for environments like university classrooms.
The researchers tested the speed and usability of this new system with two different groups. An experienced biologist who was already familiar with the old, manual way of doing this work used BUDDY to prepare for an experiment. The tool reduced the time needed for the computer-based preparation from an average of nearly nineteen minutes down to less than one minute. This dramatic speedup means that scientists can now evaluate many more variants in a single day. To test the tool's accessibility, the researchers also gave it to a first-year medical student with no prior training in computer science or genetics. After a brief demonstration, the student was able to use the platform independently to identify five specific genetic variants associated with a type of cancer and design a complete study to test them in yeast.
The study suggests that this streamlined approach could unlock a vast number of previously untestable genetic variants. By analyzing the data, the researchers estimated that roughly nine to fifteen percent of all the uncertain genetic variants found in humans could be modeled using this yeast-based method. This represents a significant portion of the genetic data that currently sits unused in medical records. The tool does not claim to solve every genetic mystery, as yeast lacks the complex tissues and organs found in humans, meaning some human-specific problems cannot be seen in a single-celled organism. However, for the variants that are conserved across species, BUDDY provides a clear, fast, and accessible path to understanding their function.
By consolidating a fragmented workflow into a single, user-friendly platform, this work demonstrates that advanced genetic research does not need to be restricted to highly specialized laboratories. The tool is designed to be open and free, allowing researchers and students in resource-limited settings to participate in the effort to decode the human genome. The ultimate goal is to turn the growing backlog of uncertain genetic findings into actionable medical knowledge, helping to clarify which genetic changes are dangerous and which are safe, thereby improving the accuracy of diagnoses and the quality of care for patients.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.